Brief: Trendlines' unit to receive clinical trial grant
29/03/2017 24:07
March 29 (Reuters) - Trendlines Group Ltd THET.SI
* Unit in partnership with Singapore General Hospital will
receive a grant from Singapore Israel Industrial Research And
Development Foundation
* Grant for development and clinical trial for its stress
urinary incontinence product
Source text for Eikon: ID:nSNZ2R4m1H
Further company coverage: THET.SI
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Trendlines
See all newsBrief: Trendlines Group Says Elastimed Enters Strategic U.S. Distribution Agreement
Brief: Trendlines Updates On Israel Situation
Brief: Trendlines Group Proposes Placement Of Up To 83.7 Mln New Shares
Brief: Trendlines Group Appoints Orit Alaluf Cohen As CFO
Brief: Trendlines Group Says Individuals To Subscribe Up To 51.4 MLN Shares At S$0.0666 Per Share